Filing Details

Accession Number:
0001593968-21-000765
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-03 16:19:04
Reporting Period:
2021-03-01
Accepted Time:
2021-03-03 16:19:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771917 Karuna Therapeutics Inc. KRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1643071 Atul Pande C/O Karuna Therapeutics, Inc.
33 Arch St Ste 3110
Boston MA 02110-1424
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-01 2,500 $16.00 2,500 No 4 M Direct
Common Stock Disposition 2021-03-01 2,500 $125.43 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2021-03-01 2,500 $0.00 2,500 $16.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
27,500 2020-06-27 2029-06-27 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.